Community Health Interventions for Renal Disease
(INSPIRE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether community health workers (CHWs) and provider education can help more people with kidney disease join the transplant waitlist. It focuses on patients with very low kidney function or those on regular dialysis, treated at specific hospitals in New York City. Patients needing community support who speak English or Spanish may find this trial suitable. The study compares two groups: one receiving extra help from CHWs and educated providers, and the other receiving usual care. As an unphased trial, this study offers patients a chance to contribute to innovative approaches in healthcare support and education.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this protocol is safe for kidney transplant patients?
Research has shown that community health workers (CHWs) are safe and helpful in caring for people with kidney disease. A workshop on CHW programs for kidney health found that these workers meet patients' social needs without causing harm, and no major negative effects were reported.
The program includes training healthcare providers to work with CHWs and enhance communication. This training is safe, as it involves no physical treatment. It aims to improve understanding and reduce bias in patient care.
Overall, using CHWs and training providers in kidney transplant support is considered safe based on current evidence.12345Why are researchers excited about this trial?
Researchers are excited about the Community Health Worker Assistance in kidney transplant support because it offers a personalized approach that current standard treatments lack. This method focuses on patient education about the transplant process and provides personalized assistance through community health workers, which is not typically part of usual care. By connecting patients with necessary social services, this approach aims to address social determinants of health, potentially leading to better transplant outcomes and improved patient engagement.
What evidence suggests that this trial's interventions could be effective for improving kidney transplant waitlisting?
This trial will compare the effectiveness of two approaches: one where participants receive assistance from community health workers (CHWs) and intervention providers, and another where participants receive usual care. Studies have shown that using CHWs and educating healthcare providers helps more patients get on the kidney transplant waiting list. Research indicates that CHWs can reduce health disparities, especially for racial and ethnic minorities with kidney disease, by connecting patients with necessary services and guiding them through the transplant process. Educating healthcare providers to collaborate with CHWs and reduce biases also improves patient outcomes. Initial findings suggest these combined efforts can make the transplant process more accessible and fair.26789
Who Is on the Research Team?
Lili Chan
Principal Investigator
Ichan School of Medicine at Mount Sinai Hospital
Are You a Good Fit for This Trial?
This trial is for patients with renal disease who are under the care of CKD/HD providers. Participants will be grouped based on their provider's random assignment to either the intervention or control group. The study aims to help those facing social challenges that affect their health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive support from community health workers and provider education to assist with the kidney transplant process
Follow-up
Participants are monitored for safety and effectiveness after intervention
Extension
Participants in the usual care group receive education and limited CHW support at the end of the study
What Are the Treatments Tested in This Trial?
Interventions
- Community Health Worker Assistance
- Intervention Providers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator